SRX Global Inc(SRXH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 23 at 4:00 AM ET (Korea 9/23 17:00)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | 2.01% | Shs Outstand | 19.5M | Perf Week | 4.09% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 19.3M | Perf Month | -4.3% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | - | Inst Own | 3.8% | Short Float | 7.9% | Perf Quarter | -66.46% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | 5.07% | Short Ratio | 0.34 | Perf Half Y | -76.22% |
| Sales | - | P/B | 0.24 | EPS next 5Y | - | ROA | - | Short Interest | 1.52M | Perf YTD | -86.67% |
| Book/sh | 7.33 | P/C | 0.71 | EPS past 3/5Y | 66.93% 63.29% | ROE | - | 52W High | -95.72% ($41.56) | Perf Year | -90.97% |
| Cash/sh | 2.52 | P/FCF | - | Sales past 3/5Y | -50.74% -31.27% | ROIC | - | 52W Low | 90.11% ($0.94) | Perf 3Y | -99.43% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 108.28% | Gross Margin | - | Volatility(W/M) | 8.94% 7.58% | Perf 5Y | -99.98% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.17 | Perf 10Y | -100% |
| Dividend Ex-Date | 2026/7/22 | Quick Ratio | 26.45 | EPS Q/Q | 98.37% | Profit Margin | - | RSI (14) | 50.35 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 27.55 | Sales Q/Q | -52.62% | SMA20 | 7.68% ($1.65) | Beta | 0.95 | Target Price | $600 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/8/13 | SMA50 | 2.73% ($1.73) | Rel Volume | 0.21 | Prev Close | $1.72 |
| Employees | 11 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -77.38% ($7.87) | Avg Volume(3M) | 4.42M | Price | $1.78 |
| IPO | 2010/6/16 | Option/Short | No/Yes | Trades | 1710 | Volume | 921,308 | Change | 3.49% |
Company
SRXH is a Consumer Defensive sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🐾 The company is a pet health company that operates Halo, a premium pet food, treat, and supplement brand for dogs and cats. It sells kibble, canned food, freeze-dried raw ingredients, and dental products through online channels like Amazon and Chewy, as well as through retail stores. Following the bankruptcy of its former subsidiary SRx Canada, the company was restructured as a pet health food-focused business.
Over the past 1 year, on the lower side
96% below its 1-year high.
SRXH makes money exceptionally well
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -99.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 3.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
VXF 0.00%It ranks #4 in the industry
Based on market cap of $35M.
SRXH $35M PER -
KHC $28B PER -
GIS $19B PER -
MKC $13B PER 8.2
FAQ
What kind of company is SRXH?
SRXH belongs to the Consumer Defensive sector and operates in the Packaged Foods industry.
What is the market cap of SRXH?
The market cap of SRXH is approximately $35M, ranking 5,099 within its sector.
What is the 52-week high and low for SRXH?
SRXH has recorded a 52-week high of $41.56 and a low of $0.94.
